Literature DB >> 22390937

Current applications of oogram methodology in experimental schistosomiasis; fecundity of female Schistosoma mansoni and egg release in the intestine of AKR/J mice following immunomodulatory treatment with pentoxifylline.

V L T Mati1, A L Melo.   

Abstract

Oogram methodology permitted a direct assessment of the fecundity of Schistosoma mansoni and the passage of parasite eggs from mesenteric vessels into the intestinal lumen in AKR/J mice that had been infected via the intraperitoneal route with 60 cercariae of the trematode and later subjected to short-term subcutaneous treatments with pentoxifylline (PTX). The administration of PTX did not change oviposition kinetics, the individual fecundity of female parasites (as determined by the study of the ratio of second-stage S. mansoni eggs per g intestine/number of female parasites recovered from the portal system), nor the number of mature and dead eggs retained in the host tissue, though the drug has known immunomodulatory effects, as shown previously in experimental schistosomiasis. A better appraisal was also carried out, including the study of statistical parameters, concerning the utilization of the ratios of each stage of immature eggs (first to fourth) per g intestine/number of female worms from the portal system. The second-stage eggs had the lowest variability, confirming that the utilization of this stage as an indicator of the individual fecundity of parasite females is indeed viable. In the light of our findings, current uses of oogram methodology are discussed. Moreover, additional consideration is given to data obtained in the present study concerning intraperitoneal infection with S. mansoni cercariae in both untreated and treated mice of the AKR/J strain, such as the recovery of mature worms, eggs and free granulomas from the peritoneal cavity of these rodents.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22390937     DOI: 10.1017/S0022149X12000144

Source DB:  PubMed          Journal:  J Helminthol        ISSN: 0022-149X            Impact factor:   2.170


  8 in total

1.  Brazilian green propolis reduces worm burden and hepatic granuloma formation in a Schistosoma mansoni experimental murine model.

Authors:  Lucas A de L Paula; Mário F C Santos; Mariana C Pagotti; Rodrigo C S Veneziani; Jairo K Bastos; Conor R Caffrey; Sérgio R Ambrósio; Lizandra G Magalhães
Journal:  Parasitol Res       Date:  2022-01-20       Impact factor: 2.289

2.  Fusion protein comprised of the two schistosomal antigens, Sm14 and Sm29, provides significant protection against Schistosoma mansoni in murine infection model.

Authors:  Shereen F Mossallam; Eglal I Amer; Radwa E Ewaisha; Amal M Khalil; Hamida M Aboushleib; Mohammed Bahey-El-Din
Journal:  BMC Infect Dis       Date:  2015-03-24       Impact factor: 3.090

3.  Protective immune responses against Schistosoma mansoni infection by immunization with functionally active gut-derived cysteine peptidases alone and in combination with glyceraldehyde 3-phosphate dehydrogenase.

Authors:  Hatem Tallima; Jan Dvořák; Sahira Kareem; Marwa Abou El Dahab; Nada Abdel Aziz; John Pius Dalton; Rashika El Ridi
Journal:  PLoS Negl Trop Dis       Date:  2017-03-27

4.  Schistosoma mansoni FES Tyrosine Kinase Involvement in the Mammalian Schistosomiasis Outcome and Miracidia Infection Capability in Biomphalaria glabrata.

Authors:  Naiara Clemente Tavares; Sandra Grossi Gava; Gabriella Parreiras Torres; Clara Ênia Soares de Paiva; Bernardo Pereira Moreira; Felipe Miguel Nery Lunkes; Langia Colli Montresor; Roberta Lima Caldeira; Marina Moraes Mourão
Journal:  Front Microbiol       Date:  2020-06-11       Impact factor: 5.640

5.  Coalescing beneficial host and deleterious antiparasitic actions as an antischistosomal strategy.

Authors:  John D Chan; Timothy A Day; Jonathan S Marchant
Journal:  Elife       Date:  2018-07-30       Impact factor: 8.140

6.  Schistosoma mansoni egg-derived extracellular vesicles: A promising vaccine candidate against murine schistosomiasis.

Authors:  Shereen F Mossallam; Iman F Abou-El-Naga; Amany Abdel Bary; Eman A Elmorsy; Radwa G Diab
Journal:  PLoS Negl Trop Dis       Date:  2021-10-13

7.  In Vivo Evaluation of an Antibody-Functionalized Lipoidal Nanosystem for Schistosomiasis Intervention.

Authors:  Tayo A Adekiya; Pradeep Kumar; Pierre P D Kondiah; Yahya E Choonara
Journal:  Pharmaceutics       Date:  2022-07-22       Impact factor: 6.525

8.  Parasitemia Evaluation in Mice Infected with Schistosoma mansoni.

Authors:  Naiara Clemente Tavares; Marina Moraes Mourão
Journal:  Bio Protoc       Date:  2021-05-20
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.